SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Transkaryotic Therapies (TKTX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: paradigm7241 who wrote (8)4/22/2000 3:26:00 AM
From: Jesse Schulman   of 12
 
"Correct me if I'm wrong" OK. You're wrong.

Your pet theory has already been tested in court and rejected.

'DNA encoding human erythropoetin'
Patent 5,756,349

Claim #1
Vertebrate cells which can be propagated in vitro and which are capable upon growth in culture of producing erythropoietin in the medium of their growth in excess of 100 U of erythropoietin per 10.sup.6 cells in 48 hours as determined by radioimmunoassay, said cells comprising NON-HUMAN DNA SEQUENCES WHICH CONTROL TRANSCRIPTION of DNA encoding human erythropoietin.

My caps.

Paradigm, you've been pushing your theory on this board and Yahoo. You're a molecular biologist, and you're explanation is based on your understanding of the science. But it's the law that's the issue. The court has considered your argument and rejected it. See the Smith Barney note for 28 March 2000, accessed by the link in my previous message.

Remember, please, AMGN only has to win one claim of infringement to win the case.

I suggest again you spend some time on the Smith Barney site, and I'd very much like to hear what you find. I suspect many of the alleged uncertainties vaunted on the message boards about this case will simply vanish as we take the trouble actually to do the reading.

itss
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News